Apollomics Inc. (APLM)
NCM · Common · CUSIP G0411D107
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for APLM and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
G0411D107
Previous Symbol
JMAC (changed 3/30/2023)
Previous Name
Maxpro Capital Acquisition Corp.
Business: Apollomics Inc. is an innovative clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer.

Company Contact

CEO
Hung-Wen Chen
CFO
Peter Lin
Headquarters
989 E. Hillsdale Blvd., Suite 220, Foster City, CA 94404
Phone
212-739-6400
Fax
650-288-1674
Investor Relations
Peter Lin · 650-209-4055 · peter.lin@apollomicsinc.com
SEC EDGAR Filings
View filings »